EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Pyrazole/pyrimidine derivatives endowed with azobenzenes as dual EGFR T790M and VEGFR-2 inhibitors: anticancer, docking, synthesis, design and ADMET assessments

Kurls E Anwer iD, Mohamed A Abdelgawad, Felemban Athary Abdulhaleem M, Nour E A Abd El-Sattar iD, Ahmed El-Morsy, Tamer Nasr iD, Mohammed Elmowafy, Khaled El-Adl iD, Naglaa M Ahmed iD

RSC Advances · 2026 · 16 (13) · 11458-11477

DOI: 10.1039/d5ra08997b ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Kurls E Anwer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Ain Shams University Abbassia Cairo Egypt. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Al Jouf University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New pyrazole/pyrimidine derivatives endowed with azobenzenes were synthesized using microwave and traditional methods.

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Ain Shams University Abbassia Cairo Egypt.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University Sakaka 72388 Saudi Arabia mhmdgwd@ju.edu.sa.
  • Department of Biology, College of Sciences, Umm Al-Qura University Makkah 21955 Saudi Arabia.
  • Basic & Medical Sciences Department, Faculty of Dentistry, Alryada University for Science & Technology Egypt.
  • Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University Nasr City Cairo 11884 Egypt.
  • Pharmaceutical Chemistry Department, College of Pharmacy, The Islamic University Najaf Iraq.

ORCID-Profile: Kurls E Anwer, Nour E A Abd El-Sattar, Tamer Nasr, Khaled El-Adl, Naglaa M Ahmed

Förderung

  • Al Jouf University

Zitieren

APA

Anwer, K. E., Abdelgawad, M. A., Abdulhaleem M, F. A., Abd El-Sattar, N. E. A., El-Morsy, A., Nasr, T., Elmowafy, M., El-Adl, K., & Ahmed, N. M. (2026). Pyrazole/pyrimidine derivatives endowed with azobenzenes as dual EGFR T790M and VEGFR-2 inhibitors: anticancer, docking, synthesis, design and ADMET assessments. RSC Advances, 16(13), 11458-11477. https://doi.org/10.1039/d5ra08997b

Vancouver

Anwer KE, Abdelgawad MA, Abdulhaleem M FA, Abd El-Sattar NEA, El-Morsy A, Nasr T, et al. Pyrazole/pyrimidine derivatives endowed with azobenzenes as dual EGFR T790M and VEGFR-2 inhibitors: anticancer, docking, synthesis, design and ADMET assessments. RSC Advances. 2026;16(13):11458-11477. doi:10.1039/d5ra08997b

BibTeX
@article{Anwer2026,
  author = {Anwer, Kurls E and Abdelgawad, Mohamed A and Abdulhaleem M, Felemban Athary and Abd El-Sattar, Nour E A and El-Morsy, Ahmed and Nasr, Tamer and Elmowafy, Mohammed and El-Adl, Khaled and Ahmed, Naglaa M},
  title = {Pyrazole/pyrimidine derivatives endowed with azobenzenes as dual EGFR T790M and VEGFR-2 inhibitors: anticancer, docking, synthesis, design and ADMET assessments},
  journal = {RSC Advances},
  year = {2026},
  volume = {16},
  number = {13},
  pages = {11458--11477},
  doi = {10.1039/d5ra08997b}
}
Kostenlos starten →